Your browser doesn't support javascript.
loading
The complex challenges of HIV vaccine development require renewed and expanded global commitment.
Bekker, Linda-Gail; Tatoud, Roger; Dabis, Francois; Feinberg, Mark; Kaleebu, Pontiano; Marovich, Mary; Ndung'u, Thumbi; Russell, Nina; Johnson, Jeremiah; Luba, Maureen; Fauci, Anthony S; Morris, Lynn; Pantaleo, Giuseppe; Buchbinder, Susan; Gray, Glenda; Vekemans, Johan; Kim, Jerome H; Levy, Yves; Corey, Lawrence; Shattock, Robin; Makanga, Michael; Williamson, Carolyn; Dieffenbach, Carl; Goodenow, Maureen M; Shao, Yiming; Staprans, Silvija; Warren, Mitchell; Johnston, Margaret I.
Afiliação
  • Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa. Electronic address: linda-gail.bekker@hiv-research.org.za.
  • Tatoud R; International AIDS Society, Geneva, Switzerland.
  • Dabis F; France Recherche Nord and Sud Sida-HIV Hépatites, Paris, France.
  • Feinberg M; International AIDS Vaccine Initiative, New York, NY, USA.
  • Kaleebu P; Medical Research Council/Uganda Virus Research Institute and The London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Marovich M; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Ndung'u T; Africa Health Research Institute, HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.
  • Russell N; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Johnson J; Treatment Action Group, New York, NY, USA.
  • Luba M; AIDS Vaccine Advocacy Coalition, New York, NY, USA.
  • Fauci AS; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Morris L; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; Center for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa; Medical Research Council Antibody Immunity Research Unit, Faculty of Health
  • Pantaleo G; Service of Immunology and Allergy and Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Buchbinder S; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
  • Gray G; South African Medical Research Council, Cape Town, South Africa.
  • Vekemans J; World Health Organization, Geneva, Switzerland.
  • Kim JH; International Vaccine Institute, Seoul, South Korea.
  • Levy Y; Vaccine Research Institute, Creteil, France; INSERM U955, University Paris-Est Créteil, Créteil, France.
  • Corey L; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Shattock R; Department of Medicine, Imperial College London, London, UK.
  • Makanga M; European and Developing Countries Clinical Trials Partnership, The Hague, Netherlands.
  • Williamson C; Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Dieffenbach C; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Goodenow MM; The Office of AIDS Research, National Institutes of Health, Bethesda, MD, USA.
  • Shao Y; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China.
  • Staprans S; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Warren M; AIDS Vaccine Advocacy Coalition, New York, NY, USA.
  • Johnston MI; International AIDS Society, Geneva, Switzerland.
Lancet ; 395(10221): 384-388, 2020 02 01.
Article em En | MEDLINE | ID: mdl-31806257

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Vacinas contra a AIDS Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Vacinas contra a AIDS Idioma: En Ano de publicação: 2020 Tipo de documento: Article